Thymol exhibits diverse bioactivities and physicochemical properties. It has a log P value of 3.3 and a log D value of 3.3, indicating moderate lipophilicity. The compound has various antimicrobial activities, including inhibition of Bacillus subtilis spore germination (IC50 of 494,000 nM), and antibacterial effects against oral and methicillin-resistant strains of Staphylococcus aureus, as well as Propionibacterium acnes with an MIC of 200 μg/mL. It also shows antifungal activity against Candida albicans and Colletotrichum species, and is effective against root-knot nematode larvae (EC50 of 160 μg/mL at 96 hours). Thymol interacts with biological membranes as indicated by permeability studies across human skin and PAMPA membranes, with log Kp of -4.83 and log Pe of -4.34, respectively. It demonstrates inhibition of COX2 enzyme at 100 μM, suggesting potential anti-inflammatory properties, and activates human TRPA1 channels (EC50 of 6,000 nM) as well as rat TRPV3 and TRPM8 channels. It also shows significant acaricidal activity against Psoroptes cuniculi and Dermatophagoides species, and nematicidal activity against Meloidogyne incognita larvae. In terms of toxicity, Thymol has an LD50 of 100 mg/kg in mice and shows gastrointestinal and neurotoxicity in Wistar rats. The compound exhibits antioxidant activity in various assays, including DPPH radical scavenging. It also inhibits SARS-CoV-2 induced cytotoxicity in cell models, and demonstrates moderate antiviral activity with an IC50 greater than 20,000 nM. Thymol shows moderate binding affinity towards multiple human receptors and enzymes, exhibiting antagonist activity at human OR5K1 and HDAC6 inhibitors, with other significant activities including potential uses in antimicrobial, antifungal, antifeedant, antioxidant, antihelminthic, and antiviral applications..
Note: Summary generated by AI. Data source: ChEMBL 